Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Niacinamide"" wg kryterium: Temat


Tytuł:
Biotransformation of flonicamid and sulfoxaflor by multifunctional bacterium Ensifer meliloti CGMCC 7333.
Autorzy:
Yang W; Jiangsu Key Laboratory for Microbes and Functional Genomics, Jiangsu Engineering and Technology Research Center for Industrialization of Microbial Resources, College of Life Science, Nanjing Normal University, Nanjing, People's Republic of China.
Fan Z; Jiangsu Key Laboratory for Microbes and Functional Genomics, Jiangsu Engineering and Technology Research Center for Industrialization of Microbial Resources, College of Life Science, Nanjing Normal University, Nanjing, People's Republic of China.
Jiang H; Jiangsu Key Laboratory for Microbes and Functional Genomics, Jiangsu Engineering and Technology Research Center for Industrialization of Microbial Resources, College of Life Science, Nanjing Normal University, Nanjing, People's Republic of China.
Zhao Y; Jiangsu Key Laboratory for Microbes and Functional Genomics, Jiangsu Engineering and Technology Research Center for Industrialization of Microbial Resources, College of Life Science, Nanjing Normal University, Nanjing, People's Republic of China.
Guo L; Jiangsu Key Laboratory for Microbes and Functional Genomics, Jiangsu Engineering and Technology Research Center for Industrialization of Microbial Resources, College of Life Science, Nanjing Normal University, Nanjing, People's Republic of China.
Dai Y; Jiangsu Key Laboratory for Microbes and Functional Genomics, Jiangsu Engineering and Technology Research Center for Industrialization of Microbial Resources, College of Life Science, Nanjing Normal University, Nanjing, People's Republic of China.
Pokaż więcej
Źródło:
Journal of environmental science and health. Part. B, Pesticides, food contaminants, and agricultural wastes [J Environ Sci Health B] 2021; Vol. 56 (2), pp. 122-131. Date of Electronic Publication: 2020 Dec 06.
Typ publikacji:
Journal Article
MeSH Terms:
Insecticides/*metabolism
Niacinamide/*analogs & derivatives
Pyridines/*metabolism
Sinorhizobium meliloti/*metabolism
Sulfur Compounds/*metabolism
Biotransformation ; Niacinamide/metabolism
Czasopismo naukowe
Tytuł:
Comparative efficacy and safety of tofacitinib, baricitinib, upadacitinib, filgotinib and peficitinib as monotherapy for active rheumatoid arthritis.
Autorzy:
Ho Lee Y; Department of Internal Medicine, Division of Rheumatology, Korea University College of Medicine, Seoul, Korea.
Gyu Song G; Department of Internal Medicine, Division of Rheumatology, Korea University College of Medicine, Seoul, Korea.
Pokaż więcej
Źródło:
Journal of clinical pharmacy and therapeutics [J Clin Pharm Ther] 2020 Aug; Vol. 45 (4), pp. 674-681. Date of Electronic Publication: 2020 Jun 03.
Typ publikacji:
Comparative Study; Journal Article; Meta-Analysis
MeSH Terms:
Adamantane/*analogs & derivatives
Antirheumatic Agents/*therapeutic use
Arthritis, Rheumatoid/*drug therapy
Azetidines/*therapeutic use
Heterocyclic Compounds, 3-Ring/*therapeutic use
Niacinamide/*analogs & derivatives
Piperidines/*therapeutic use
Purines/*therapeutic use
Pyrazoles/*therapeutic use
Pyridines/*therapeutic use
Pyrimidines/*therapeutic use
Sulfonamides/*therapeutic use
Triazoles/*therapeutic use
Adamantane/therapeutic use ; Bayes Theorem ; Humans ; Niacinamide/therapeutic use ; Randomized Controlled Trials as Topic
Czasopismo naukowe
Tytuł:
An Improved Method for the Quaternization of Nicotinamide and Antifungal Activities of Its Derivatives.
Autorzy:
Siber T; Faculty of Agrobiotechnical Sciences, Josip Juraj Strossmayer University of Osijek, Vladimira Preloga 1, HR⁻31000 Osijek, Croatia. .
Bušić V; Faculty of Food Technology, Josip Juraj Strossmayer University of Osijek, Kuhačeva 20, HR⁻31000 Osijek, Croatia. .
Zobundžija D; Faculty of Food Technology, Josip Juraj Strossmayer University of Osijek, Kuhačeva 20, HR⁻31000 Osijek, Croatia. .
Roca S; NMR Centre, Ruđer Bošković Institute, Bijenička cesta 54, HR⁻10000 Zagreb, Croatia. .
Vikić-Topić D; NMR Centre, Ruđer Bošković Institute, Bijenička cesta 54, HR⁻10000 Zagreb, Croatia. .; Department of Natural and Health Sciences, Juraj Dobrila University of Pula, Zagrebačka 30, HR⁻52100 Pula, Croatia. .
Vrandečić K; Faculty of Agrobiotechnical Sciences, Josip Juraj Strossmayer University of Osijek, Vladimira Preloga 1, HR⁻31000 Osijek, Croatia. .
Gašo-Sokač D; Faculty of Food Technology, Josip Juraj Strossmayer University of Osijek, Kuhačeva 20, HR⁻31000 Osijek, Croatia. .
Pokaż więcej
Źródło:
Molecules (Basel, Switzerland) [Molecules] 2019 Mar 13; Vol. 24 (6). Date of Electronic Publication: 2019 Mar 13.
Typ publikacji:
Journal Article
MeSH Terms:
Antifungal Agents/*chemical synthesis
Ascomycota/*drug effects
Fusarium/*drug effects
Niacinamide/*analogs & derivatives
Pyridines/*chemical synthesis
Acetophenones/chemistry ; Antifungal Agents/chemistry ; Antifungal Agents/pharmacology ; Hydrocarbons, Iodinated/chemistry ; Magnetic Resonance Spectroscopy ; Microbial Sensitivity Tests ; Microwaves ; Molecular Structure ; Niacinamide/chemistry ; Pyridines/chemistry ; Pyridines/pharmacology
Czasopismo naukowe
Tytuł:
N-Labelled Pyridine and Nicotinamide.
Autorzy:
Svyatova A; International Tomography Center, SB RAS, 3A Institutskaya st., Novosibirsk, 630090, Russia.; Novosibirsk State University, 2 Pirogova st., Novosibirsk, 630090, Russia.
Skovpin IV; International Tomography Center, SB RAS, 3A Institutskaya st., Novosibirsk, 630090, Russia.; Novosibirsk State University, 2 Pirogova st., Novosibirsk, 630090, Russia.
Chukanov NV; International Tomography Center, SB RAS, 3A Institutskaya st., Novosibirsk, 630090, Russia.; Novosibirsk State University, 2 Pirogova st., Novosibirsk, 630090, Russia.
Kovtunov KV; International Tomography Center, SB RAS, 3A Institutskaya st., Novosibirsk, 630090, Russia.; Novosibirsk State University, 2 Pirogova st., Novosibirsk, 630090, Russia.
Chekmenev EY; Department of Chemistry, Wayne State University, Karmanos Cancer Institute (KCI), Integrative Biosciences (Ibio), Detroit, MI 48202, USA.; Russian Academy of Sciences (RAS), 14 Leninskiy Prospekt, Moscow, 119991, Russia.
Pravdivtsev AN; Section Biomedical Imaging, Molecular Imaging North Competence Center (MOIN CC), Department of Radiology and Neuroradiology University Medical Center Schleswig-Holstein (UKSH), Kiel University, Am Botanischen Garten 14, 24118, Kiel, Germany.
Hövener JB; Section Biomedical Imaging, Molecular Imaging North Competence Center (MOIN CC), Department of Radiology and Neuroradiology University Medical Center Schleswig-Holstein (UKSH), Kiel University, Am Botanischen Garten 14, 24118, Kiel, Germany.
Koptyug IV; International Tomography Center, SB RAS, 3A Institutskaya st., Novosibirsk, 630090, Russia.; Novosibirsk State University, 2 Pirogova st., Novosibirsk, 630090, Russia.
Pokaż więcej
Źródło:
Chemistry (Weinheim an der Bergstrasse, Germany) [Chemistry] 2019 Jun 26; Vol. 25 (36), pp. 8465-8470. Date of Electronic Publication: 2019 May 27.
Typ publikacji:
Journal Article
MeSH Terms:
Magnetic Resonance Imaging/*methods
Niacinamide/*chemistry
Pyridines/*chemistry
Catalysis ; Coordination Complexes/chemistry ; Isotope Labeling ; Nitrogen Isotopes/chemistry
Czasopismo naukowe
Tytuł:
The effects of 1,4-dimethylpyridine in metastatic prostate cancer in mice.
Autorzy:
Denslow A; Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Weigla 12, Wroclaw, 53-114, Poland.
Switalska M; Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Weigla 12, Wroclaw, 53-114, Poland.
Nowak M; Wroclaw University of Environmental and Life Sciences, Norwida 31, Wroclaw, 50-375, Poland.
Maciejewska M; Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Weigla 12, Wroclaw, 53-114, Poland.
Chlopicki S; Chair of Pharmacology, Jagiellonian University, Medical College, Grzegorzecka 16, Krakow, 31-531, Poland.; Jagiellonian Center for Experimental Therapeutics (JCET), Jagiellonian University, Bobrzynskiego 14, Krakow, 30-348, Poland.
Marcinek A; Lodz University of Technology, Zeromskiego 116, Lodz, 90-924, Poland.
Gebicki J; Lodz University of Technology, Zeromskiego 116, Lodz, 90-924, Poland.
Wietrzyk J; Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Weigla 12, Wroclaw, 53-114, Poland. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2017 Mar 07; Vol. 17 (1), pp. 177. Date of Electronic Publication: 2017 Mar 07.
Typ publikacji:
Journal Article
MeSH Terms:
Antineoplastic Combined Chemotherapy Protocols/*administration & dosage
Niacinamide/*analogs & derivatives
Prostatic Neoplasms/*drug therapy
Pyridines/*administration & dosage
Animals ; Cyclophosphamide/administration & dosage ; Disease Models, Animal ; Docetaxel ; Humans ; Male ; Mice ; Neoplasm Metastasis ; Niacinamide/administration & dosage ; Prostatic Neoplasms/pathology ; Taxoids/administration & dosage
Czasopismo naukowe
Tytuł:
Identification of Novel Small Molecule Inhibitors of Oncogenic RET Kinase.
Autorzy:
Moccia M; Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università di Napoli 'Federico II', Naples, Italy; Istituto di Endocrinologia ed Oncologia Sperimentale del CNR, Naples, Italy.
Liu Q; Department of Cancer Biology, Dana Farber Cancer Institute, Boston, Massachusetts United States of America; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts, United States of America.
Guida T; Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università di Napoli 'Federico II', Naples, Italy; Istituto di Endocrinologia ed Oncologia Sperimentale del CNR, Naples, Italy.
Federico G; Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università di Napoli 'Federico II', Naples, Italy; Istituto di Endocrinologia ed Oncologia Sperimentale del CNR, Naples, Italy.
Brescia A; Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università di Napoli 'Federico II', Naples, Italy; Istituto di Endocrinologia ed Oncologia Sperimentale del CNR, Naples, Italy.
Zhao Z; High Magnetic Field Laboratory, Chinese Academy of Sciences, Hefei, Anhui, P.R. China.
Choi HG; Department of Cancer Biology, Dana Farber Cancer Institute, Boston, Massachusetts United States of America; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts, United States of America.
Deng X; Department of Cancer Biology, Dana Farber Cancer Institute, Boston, Massachusetts United States of America; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts, United States of America.
Tan L; Department of Cancer Biology, Dana Farber Cancer Institute, Boston, Massachusetts United States of America; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts, United States of America.
Wang J; Department of Cancer Biology, Dana Farber Cancer Institute, Boston, Massachusetts United States of America; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts, United States of America.
Billaud M; Institut Albert Bonniot, CRI INSERM/UJF U823, La Tronche Cedex, France.
Gray NS; Department of Cancer Biology, Dana Farber Cancer Institute, Boston, Massachusetts United States of America; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts, United States of America.
Carlomagno F; Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università di Napoli 'Federico II', Naples, Italy; Istituto di Endocrinologia ed Oncologia Sperimentale del CNR, Naples, Italy.
Santoro M; Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università di Napoli 'Federico II', Naples, Italy; Istituto di Endocrinologia ed Oncologia Sperimentale del CNR, Naples, Italy.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2015 Jun 05; Vol. 10 (6), pp. e0128364. Date of Electronic Publication: 2015 Jun 05 (Print Publication: 2015).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Benzamides/*chemistry
Niacinamide/*analogs & derivatives
Protein Kinase Inhibitors/*chemistry
Proto-Oncogene Proteins c-ret/*antagonists & inhibitors
Pyridines/*chemistry
Small Molecule Libraries/*chemistry
Animals ; Benzamides/metabolism ; Benzamides/toxicity ; Cell Line, Tumor ; Cell Proliferation/drug effects ; Humans ; Mice ; Molecular Docking Simulation ; Mutation ; NIH 3T3 Cells ; Niacinamide/chemistry ; Niacinamide/metabolism ; Niacinamide/toxicity ; Phosphorylation/drug effects ; Protein Binding ; Protein Kinase Inhibitors/metabolism ; Protein Kinase Inhibitors/toxicity ; Protein Structure, Tertiary ; Proto-Oncogene Proteins c-ret/genetics ; Proto-Oncogene Proteins c-ret/metabolism ; Pyridines/metabolism ; Pyridines/toxicity ; Small Molecule Libraries/metabolism ; Small Molecule Libraries/toxicity ; Transfection
Czasopismo naukowe
Tytuł:
Antagonism of sorafenib and regorafenib actions by platelet factors in hepatocellular carcinoma cell lines.
Autorzy:
D'Alessandro R
Refolo MG
Lippolis C
Giannuzzi G
Carella N
Messa C
Cavallini A
Carr BI; Laboratory of Biochemistry, National Institute for Digestive Diseases, IRCCS 'Saverio de Bellis', Via Turi 27, 70013, Castellana Grotte, BA, Italy. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2014 May 21; Vol. 14, pp. 351. Date of Electronic Publication: 2014 May 21.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Antineoplastic Agents/*pharmacology
Blood Platelets/*metabolism
Carcinoma, Hepatocellular/*metabolism
Liver Neoplasms/*metabolism
Niacinamide/*analogs & derivatives
Phenylurea Compounds/*pharmacology
Protein Kinase Inhibitors/*pharmacology
Pyridines/*pharmacology
Apoptosis/drug effects ; Apoptosis Regulatory Proteins/metabolism ; Carcinoma, Hepatocellular/pathology ; Cell Movement/drug effects ; Cell Proliferation/drug effects ; Enzyme Activation ; Epidermal Growth Factor/blood ; Extracellular Signal-Regulated MAP Kinases/metabolism ; Hep G2 Cells ; Humans ; Insulin-Like Growth Factor I/metabolism ; Liver Neoplasms/pathology ; Neoplasm Invasiveness ; Niacinamide/pharmacology ; Phosphorylation ; Signal Transduction/drug effects ; Sorafenib ; Time Factors
Czasopismo naukowe
Tytuł:
Blockade of the brain histamine H3 receptor by JNJ-39220675: preclinical PET studies with [¹¹C]GSK189254 in anesthetized baboon.
Autorzy:
Logan J; Medical Department, Brookhaven National Laboratory, Upton, NY 11973, USA. />Carruthers NI
Letavic MA
Sands S
Jiang X
Shea C
Muench L
Xu Y
Carter P
King P
Fowler JS
Pokaż więcej
Źródło:
Psychopharmacology [Psychopharmacology (Berl)] 2012 Oct; Vol. 223 (4), pp. 447-55. Date of Electronic Publication: 2012 May 22.
Typ publikacji:
Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:
Azepines/*pharmacology
Benzazepines/*pharmacology
Histamine H3 Antagonists/*pharmacology
Niacinamide/*analogs & derivatives
Pyridines/*pharmacology
Receptors, Histamine H3/*drug effects
Administration, Oral ; Animals ; Azepines/administration & dosage ; Azepines/pharmacokinetics ; Benzazepines/administration & dosage ; Benzazepines/pharmacokinetics ; Blood-Brain Barrier/metabolism ; Brain/metabolism ; Dose-Response Relationship, Drug ; Female ; Histamine H3 Antagonists/administration & dosage ; Histamine H3 Antagonists/pharmacokinetics ; Injections, Intravenous ; Niacinamide/administration & dosage ; Niacinamide/pharmacokinetics ; Niacinamide/pharmacology ; Papio ; Positron-Emission Tomography ; Pyridines/administration & dosage ; Pyridines/pharmacokinetics ; Radiopharmaceuticals/administration & dosage ; Radiopharmaceuticals/pharmacokinetics ; Radiopharmaceuticals/pharmacology ; Receptors, Histamine H3/metabolism ; Sensitivity and Specificity ; Time Factors ; Tissue Distribution
Czasopismo naukowe
Tytuł:
Crystal engineering: co-crystals of cinnamic acid derivatives with a pyridyl derivative co-crystallizer.
Autorzy:
Lorenzo DA; Department of Chemistry, University of Bristol, Cantock's Close, Bristol BS8 1TS, England.
Forrest SJ; Department of Chemistry, University of Bristol, Cantock's Close, Bristol BS8 1TS, England.
Sparkes HA; Department of Chemistry, University of Bristol, Cantock's Close, Bristol BS8 1TS, England.
Pokaż więcej
Źródło:
Acta crystallographica Section B, Structural science, crystal engineering and materials [Acta Crystallogr B Struct Sci Cryst Eng Mater] 2016 Feb; Vol. 72 (Pt 1), pp. 87-95. Date of Electronic Publication: 2016 Jan 29.
Typ publikacji:
Journal Article
MeSH Terms:
Cinnamates/*chemistry
Niacinamide/*chemistry
Pyridines/*chemistry
Crystallization ; Crystallography, X-Ray ; Models, Molecular ; X-Ray Diffraction
Czasopismo naukowe
Tytuł:
An unusual pyridine nucleotide accumulating in erythrocytes: its identity and positive correlation with degree of renal failure.
Autorzy:
Carrey EA; University College London, Institute of Child Health, London, UK. />Smolenski RT
Edbury SM
Laurence A
Marinaki AM
Duley JA
Zhu LM
Goldsmith DJ
Simmonds HA
Pokaż więcej
Źródło:
Nucleosides, nucleotides & nucleic acids [Nucleosides Nucleotides Nucleic Acids] 2004 Oct; Vol. 23 (8-9), pp. 1135-9.
Typ publikacji:
Journal Article
MeSH Terms:
Erythrocytes/*metabolism
Niacinamide/*analogs & derivatives
Nucleotides/*chemistry
Pyridines/*chemistry
Renal Insufficiency/*drug therapy
Chromatography, High Pressure Liquid ; Chromatography, Liquid ; Humans ; Kidney/metabolism ; Mass Spectrometry ; Niacinamide/chemistry ; Niacinamide/pharmacology ; Pyrimidine Nucleotides/metabolism ; Renal Insufficiency/blood ; Renal Insufficiency/urine ; Time Factors ; Ultraviolet Rays ; Uremia/blood
Czasopismo naukowe
Tytuł:
High activity of sorafenib in FLT3-ITD-positive acute myeloid leukemia synergizes with allo-immune effects to induce sustained responses.
Autorzy:
Metzelder SK; Philipps Universität Marburg, Universitätsklinikum Gießen und Marburg, Standort Marburg, Klinik für Hämatologie, Onkologie und Immunologie, Marburg, Germany.
Schroeder T
Finck A
Scholl S
Fey M
Götze K
Linn YC
Kröger M
Reiter A
Salih HR
Heinicke T
Stuhlmann R
Müller L
Giagounidis A
Meyer RG
Brugger W
Vöhringer M
Dreger P
Mori M
Basara N
Schäfer-Eckart K
Schultheis B
Baldus C
Neubauer A
Burchert A
Pokaż więcej
Źródło:
Leukemia [Leukemia] 2012 Nov; Vol. 26 (11), pp. 2353-9. Date of Electronic Publication: 2012 Apr 16.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antineoplastic Agents/*therapeutic use
Benzenesulfonates/*therapeutic use
Leukemia, Myeloid, Acute/*drug therapy
Pyridines/*therapeutic use
fms-Like Tyrosine Kinase 3/*metabolism
Aged ; Female ; Humans ; Leukemia, Myeloid, Acute/immunology ; Leukemia, Myeloid, Acute/metabolism ; Leukemia, Myeloid, Acute/pathology ; Male ; Middle Aged ; Niacinamide/analogs & derivatives ; Phenylurea Compounds ; Retrospective Studies ; Sorafenib
Czasopismo naukowe
Tytuł:
Sorafenib rechallenge in patients with metastatic renal cell carcinoma.
Autorzy:
Nozawa M; Department of Urology, Kinki University Faculty of Medicine, Osaka-Sayama, Osaka, Japan. />Yamamoto Y
Minami T
Shimizu N
Hatanaka Y
Tsuji H
Uemura H
Pokaż więcej
Źródło:
BJU international [BJU Int] 2012 Sep; Vol. 110 (6 Pt B), pp. E228-34. Date of Electronic Publication: 2012 Feb 14.
Typ publikacji:
Journal Article
MeSH Terms:
Antineoplastic Agents/*therapeutic use
Benzenesulfonates/*therapeutic use
Carcinoma, Renal Cell/*drug therapy
Carcinoma, Renal Cell/*secondary
Kidney Neoplasms/*drug therapy
Kidney Neoplasms/*pathology
Pyridines/*therapeutic use
Aged ; Aged, 80 and over ; Female ; Humans ; Male ; Middle Aged ; Niacinamide/analogs & derivatives ; Phenylurea Compounds ; Retreatment ; Retrospective Studies ; Sorafenib
Czasopismo naukowe
Tytuł:
Use of tyrosine kinase inhibitors in patients with metastatic kidney cancer receiving haemodialysis: a retrospective Italian survey.
Autorzy:
Masini C; Department of Oncology, Hematology and Respiratory Diseases, University of Modena and Reggio Emilia, Modena, Italy. />Sabbatini R
Porta C
Procopio G
Di Lorenzo G
Onofri A
Buti S
Iacovelli R
Invernizzi R
Moscetti L
Aste MG
Pagano M
Grosso F
Lucia Manenti A
Ortega C
Cosmai L
Del Giovane C
Conte PF
Pokaż więcej
Źródło:
BJU international [BJU Int] 2012 Sep; Vol. 110 (5), pp. 692-8. Date of Electronic Publication: 2012 Feb 24.
Typ publikacji:
Journal Article
MeSH Terms:
Renal Dialysis*
Antineoplastic Agents/*administration & dosage
Benzenesulfonates/*administration & dosage
Indoles/*administration & dosage
Kidney Neoplasms/*drug therapy
Protein Kinase Inhibitors/*administration & dosage
Pyridines/*administration & dosage
Pyrroles/*administration & dosage
Aged ; Aged, 80 and over ; Contraindications ; Female ; Humans ; Kidney Failure, Chronic/therapy ; Male ; Middle Aged ; Neoplasm Metastasis ; Niacinamide/analogs & derivatives ; Phenylurea Compounds ; Retrospective Studies ; Sorafenib ; Sunitinib
Czasopismo naukowe
Tytuł:
Sorafenib rechalenge in metastatic renal cell carcinoma.
Autorzy:
Porta C
Paglino C
Imarisio I
Pokaż więcej
Źródło:
BJU international [BJU Int] 2012 Sep; Vol. 110 (6 Pt B), pp. E235. Date of Electronic Publication: 2012 Feb 14.
Typ publikacji:
Editorial; Comment
MeSH Terms:
Antineoplastic Agents/*therapeutic use
Benzenesulfonates/*therapeutic use
Carcinoma, Renal Cell/*drug therapy
Carcinoma, Renal Cell/*secondary
Kidney Neoplasms/*drug therapy
Kidney Neoplasms/*pathology
Pyridines/*therapeutic use
Female ; Humans ; Male ; Niacinamide/analogs & derivatives ; Phenylurea Compounds ; Sorafenib
Opinia redakcyjna
Tytuł:
Sorafenib use in hepatocellular carcinoma in Japan: early experience and impact on clinical practice.
Autorzy:
Zhu AX; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.
Pokaż więcej
Źródło:
Clinical drug investigation [Clin Drug Investig] 2012 Aug 08; Vol. 32 Suppl 2, pp. 1-2.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antineoplastic Agents/*therapeutic use
Benzenesulfonates/*therapeutic use
Carcinoma, Hepatocellular/*drug therapy
Liver Neoplasms/*drug therapy
Pyridines/*therapeutic use
Carcinoma, Hepatocellular/epidemiology ; Carcinoma, Hepatocellular/pathology ; Humans ; Japan/epidemiology ; Liver Neoplasms/epidemiology ; Liver Neoplasms/pathology ; Neoplasm Staging ; Niacinamide/analogs & derivatives ; Phenylurea Compounds ; Risk Factors ; Sorafenib ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Current status of hepatocellular carcinoma treatment in Japan: case study and discussion-voting system.
Autorzy:
Kudo M; Department of Gastroenterology and Hepatology, Kinki University School of Medicine, 377-2 Ohno-Higashi, Osaka-Sayama, Osaka, Japan. />Tateishi R
Yamashita T
Ikeda M
Furuse J
Ikeda K
Kokudo N
Izumi N
Matsui O
Pokaż więcej
Źródło:
Clinical drug investigation [Clin Drug Investig] 2012 Aug 08; Vol. 32 Suppl 2, pp. 37-51.
Typ publikacji:
Congress; Research Support, Non-U.S. Gov't
MeSH Terms:
Antineoplastic Agents/*therapeutic use
Benzenesulfonates/*therapeutic use
Carcinoma, Hepatocellular/*drug therapy
Liver Neoplasms/*drug therapy
Pyridines/*therapeutic use
Carcinoma, Hepatocellular/pathology ; Humans ; Japan ; Liver Neoplasms/pathology ; Niacinamide/analogs & derivatives ; Phenylurea Compounds ; Practice Guidelines as Topic ; Sorafenib ; Time Factors
Raport
Tytuł:
Current status of hepatocellular carcinoma treatment in Japan: practical use of sorafenib (Nexavar®).
Autorzy:
Kokudo N; Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine, University of Tokyo, 7-3-1 Hongo,Bunkyo-ku, Tokyo, Japan. />Nakajima J
Hatano E
Numata K
Pokaż więcej
Źródło:
Clinical drug investigation [Clin Drug Investig] 2012 Aug 08; Vol. 32 Suppl 2, pp. 25-35.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms:
Antineoplastic Agents/*therapeutic use
Benzenesulfonates/*therapeutic use
Carcinoma, Hepatocellular/*drug therapy
Liver Neoplasms/*drug therapy
Pyridines/*therapeutic use
Antineoplastic Agents/administration & dosage ; Antineoplastic Agents/adverse effects ; Benzenesulfonates/administration & dosage ; Benzenesulfonates/adverse effects ; Carcinoma, Hepatocellular/pathology ; Clinical Trials as Topic ; Dose-Response Relationship, Drug ; Humans ; Japan ; Liver Neoplasms/pathology ; Medication Adherence ; Niacinamide/analogs & derivatives ; Patient Education as Topic ; Phenylurea Compounds ; Pyridines/administration & dosage ; Pyridines/adverse effects ; Sorafenib ; Time Factors
Czasopismo naukowe
Tytuł:
Phase I study investigating the safety and feasibility of combining imatinib mesylate (Gleevec) with sorafenib in patients with refractory castration-resistant prostate cancer.
Autorzy:
Nabhan C; Department of Medicine, Division of Hematology and Oncology, Advocate Lutheran General Hospital, Park Ridge, IL, USA. />Villines D
Valdez TV
Tolzien K
Lestingi TM
Bitran JD
Christner SM
Egorin MJ
Beumer JH
Pokaż więcej
Źródło:
British journal of cancer [Br J Cancer] 2012 Aug 07; Vol. 107 (4), pp. 592-7. Date of Electronic Publication: 2012 Jul 17.
Typ publikacji:
Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Benzenesulfonates/*administration & dosage
Piperazines/*administration & dosage
Prostatic Neoplasms/*drug therapy
Pyridines/*administration & dosage
Pyrimidines/*administration & dosage
Adult ; Aged ; Aged, 80 and over ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Benzamides ; Castration ; Drug Administration Schedule ; Humans ; Imatinib Mesylate ; Male ; Maximum Tolerated Dose ; Middle Aged ; Niacinamide/analogs & derivatives ; Phenylurea Compounds ; Piperazines/pharmacokinetics ; Pyrimidines/pharmacokinetics ; Retreatment ; Sorafenib ; Treatment Failure
Czasopismo naukowe
Tytuł:
Sorafenib in advanced melanoma: a critical role for pharmacokinetics?
Autorzy:
Pécuchet N; Department of Medical Oncology, Centre for Research on Angiogenesis Inhibitors (CERIA), Cochin Teaching Hospital, Université Paris Descartes, Sorbonne Paris Cité, AP-HP, 27, rue du faubourg Saint Jacques, F75014 Paris, France.
Lebbe C
Mir O
Billemont B
Blanchet B
Franck N
Viguier M
Coriat R
Tod M
Avril MF
Goldwasser F
Pokaż więcej
Źródło:
British journal of cancer [Br J Cancer] 2012 Jul 24; Vol. 107 (3), pp. 455-61. Date of Electronic Publication: 2012 Jul 05.
Typ publikacji:
Clinical Trial; Journal Article
MeSH Terms:
Antineoplastic Agents/*pharmacokinetics
Antineoplastic Agents/*therapeutic use
Benzenesulfonates/*pharmacokinetics
Benzenesulfonates/*therapeutic use
Melanoma/*drug therapy
Melanoma/*metabolism
Pyridines/*pharmacokinetics
Pyridines/*therapeutic use
Adult ; Aged ; Aged, 80 and over ; Antineoplastic Agents/adverse effects ; Antineoplastic Agents/blood ; Benzenesulfonates/adverse effects ; Benzenesulfonates/blood ; Disease-Free Survival ; Female ; Humans ; Male ; Melanoma/blood ; Middle Aged ; Multivariate Analysis ; Niacinamide/analogs & derivatives ; Phenylurea Compounds ; Pyridines/adverse effects ; Pyridines/blood ; Retrospective Studies ; Sorafenib
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies